Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers

Alcon

Status and phase: Completed; Phase 4

Conditions: Glaucoma

Treatments: Drug: Travatan® Z; Drug: Xalatan®

Study type: Interventional

Funder types: Industry

Identifiers

NCT00468988

SMA-06-21

Details and patient eligibility

About

Compare the effect of Xalatan with benzalkonium chloride on the ocular surface to those effects observed with Travatan Z without benzalkonium chloride after a single dose

Enrollment: 30 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Adults with primary open-angle glaucoma, ocular hypertension or pigment dispersion glaucoma

Exclusion criteria

• Age

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Single Blind